The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prenatal DNA Sequencing Market Research Report 2025
Synopsis
DNA sequencing is the process used to determine the sequence of nucleotides within a DNA molecule.Prenatal DNA sequencing is a method of sequencing DNA isolated from the blood of a pregnant woman to reveal the complete genetic code of the fetus.Prenatal DNA sequencing is used to sequence the entire genome of an unborn baby, effectively detecting diseases or conditions such as down syndrome, cystic fibrosis, thalassemia and cancer.
The global Prenatal DNA Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prenatal DNA Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prenatal DNA Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prenatal DNA Sequencing in Hemophilia is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prenatal DNA Sequencing include BGI, Agilent Technologies, Roche, Illumina, LabCorp, Natera and Twist Bioscience, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prenatal DNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal DNA Sequencing.
Report Scope
The Prenatal DNA Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prenatal DNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prenatal DNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BGI
Agilent Technologies
Roche
Illumina
LabCorp
Natera
Twist Bioscience
Segment by Type
Genetic Disorders
Nonhereditary Disease
Segment by Application
Hemophilia
Down Syndrome
Cystic Fibrosis
Autism
DiGeorge Syndrome
AIDS
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prenatal DNA Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
DNA sequencing is the process used to determine the sequence of nucleotides within a DNA molecule.Prenatal DNA sequencing is a method of sequencing DNA isolated from the blood of a pregnant woman to reveal the complete genetic code of the fetus.Prenatal DNA sequencing is used to sequence the entire genome of an unborn baby, effectively detecting diseases or conditions such as down syndrome, cystic fibrosis, thalassemia and cancer.
The global Prenatal DNA Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prenatal DNA Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prenatal DNA Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prenatal DNA Sequencing in Hemophilia is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prenatal DNA Sequencing include BGI, Agilent Technologies, Roche, Illumina, LabCorp, Natera and Twist Bioscience, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prenatal DNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal DNA Sequencing.
Report Scope
The Prenatal DNA Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prenatal DNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prenatal DNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BGI
Agilent Technologies
Roche
Illumina
LabCorp
Natera
Twist Bioscience
Segment by Type
Genetic Disorders
Nonhereditary Disease
Segment by Application
Hemophilia
Down Syndrome
Cystic Fibrosis
Autism
DiGeorge Syndrome
AIDS
Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prenatal DNA Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal DNA Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genetic Disorders
1.2.3 Nonhereditary Disease
1.3 Market by Application
1.3.1 Global Prenatal DNA Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hemophilia
1.3.3 Down Syndrome
1.3.4 Cystic Fibrosis
1.3.5 Autism
1.3.6 DiGeorge Syndrome
1.3.7 AIDS
1.3.8 Cancer
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prenatal DNA Sequencing Market Perspective (2019-2030)
2.2 Prenatal DNA Sequencing Growth Trends by Region
2.2.1 Global Prenatal DNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prenatal DNA Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Prenatal DNA Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Prenatal DNA Sequencing Market Dynamics
2.3.1 Prenatal DNA Sequencing Industry Trends
2.3.2 Prenatal DNA Sequencing Market Drivers
2.3.3 Prenatal DNA Sequencing Market Challenges
2.3.4 Prenatal DNA Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal DNA Sequencing Players by Revenue
3.1.1 Global Top Prenatal DNA Sequencing Players by Revenue (2019-2024)
3.1.2 Global Prenatal DNA Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Prenatal DNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prenatal DNA Sequencing Revenue
3.4 Global Prenatal DNA Sequencing Market Concentration Ratio
3.4.1 Global Prenatal DNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal DNA Sequencing Revenue in 2023
3.5 Prenatal DNA Sequencing Key Players Head office and Area Served
3.6 Key Players Prenatal DNA Sequencing Product Solution and Service
3.7 Date of Enter into Prenatal DNA Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal DNA Sequencing Breakdown Data by Type
4.1 Global Prenatal DNA Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Prenatal DNA Sequencing Forecasted Market Size by Type (2025-2030)
5 Prenatal DNA Sequencing Breakdown Data by Application
5.1 Global Prenatal DNA Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Prenatal DNA Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prenatal DNA Sequencing Market Size (2019-2030)
6.2 North America Prenatal DNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prenatal DNA Sequencing Market Size by Country (2019-2024)
6.4 North America Prenatal DNA Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prenatal DNA Sequencing Market Size (2019-2030)
7.2 Europe Prenatal DNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prenatal DNA Sequencing Market Size by Country (2019-2024)
7.4 Europe Prenatal DNA Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prenatal DNA Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Prenatal DNA Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prenatal DNA Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Prenatal DNA Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prenatal DNA Sequencing Market Size (2019-2030)
9.2 Latin America Prenatal DNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prenatal DNA Sequencing Market Size by Country (2019-2024)
9.4 Latin America Prenatal DNA Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prenatal DNA Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Prenatal DNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prenatal DNA Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Prenatal DNA Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BGI
11.1.1 BGI Company Detail
11.1.2 BGI Business Overview
11.1.3 BGI Prenatal DNA Sequencing Introduction
11.1.4 BGI Revenue in Prenatal DNA Sequencing Business (2019-2024)
11.1.5 BGI Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Prenatal DNA Sequencing Introduction
11.2.4 Agilent Technologies Revenue in Prenatal DNA Sequencing Business (2019-2024)
11.2.5 Agilent Technologies Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Prenatal DNA Sequencing Introduction
11.3.4 Roche Revenue in Prenatal DNA Sequencing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Prenatal DNA Sequencing Introduction
11.4.4 Illumina Revenue in Prenatal DNA Sequencing Business (2019-2024)
11.4.5 Illumina Recent Development
11.5 LabCorp
11.5.1 LabCorp Company Detail
11.5.2 LabCorp Business Overview
11.5.3 LabCorp Prenatal DNA Sequencing Introduction
11.5.4 LabCorp Revenue in Prenatal DNA Sequencing Business (2019-2024)
11.5.5 LabCorp Recent Development
11.6 Natera
11.6.1 Natera Company Detail
11.6.2 Natera Business Overview
11.6.3 Natera Prenatal DNA Sequencing Introduction
11.6.4 Natera Revenue in Prenatal DNA Sequencing Business (2019-2024)
11.6.5 Natera Recent Development
11.7 Twist Bioscience
11.7.1 Twist Bioscience Company Detail
11.7.2 Twist Bioscience Business Overview
11.7.3 Twist Bioscience Prenatal DNA Sequencing Introduction
11.7.4 Twist Bioscience Revenue in Prenatal DNA Sequencing Business (2019-2024)
11.7.5 Twist Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
